Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study.

Suzuki H, Matsuzaki J, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Kobayakawa M, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, Tack J; Rikkunshito study group..

Neurogastroenterol Motil. 2014 Jul;26(7):950-61. doi: 10.1111/nmo.12348.

2.

Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia.

Togawa K, Matsuzaki J, Kobayakawa M, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, Suzuki H.

J Gastroenterol Hepatol. 2016 Feb;31(2):334-41. doi: 10.1111/jgh.13074.

PMID:
26252950
3.

Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin.

Arai M, Matsumura T, Tsuchiya N, Sadakane C, Inami R, Suzuki T, Yoshikawa M, Imazeki F, Yokosuka O.

Hepatogastroenterology. 2012 Jan-Feb;59(113):62-6. doi: 10.5754/hge11246.

PMID:
22260823
4.

Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.

Lan L, Yu J, Chen YL, Zhong YL, Zhang H, Jia CH, Yuan Y, Liu BW.

World J Gastroenterol. 2011 Jul 21;17(27):3242-7. doi: 10.3748/wjg.v17.i27.3242.

5.

Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.

Futagami S, Shimpuku M, Song JM, Kodaka Y, Yamawaki H, Nagoya H, Shindo T, Kawagoe T, Horie A, Gudis K, Iwakiri K, Sakamoto C.

Digestion. 2012;86(2):114-21. doi: 10.1159/000339111.

PMID:
22846371
6.

Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.

Zhang S, Zhao L, Wang H, Wang C, Huang S, Shen H, Wei W, Tao L, Zhou T.

BMC Complement Altern Med. 2013 Mar 2;13:54. doi: 10.1186/1472-6882-13-54.

7.
8.

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.

Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ.

Aliment Pharmacol Ther. 2000 Dec;14(12):1653-61.

9.

[Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study].

Shim YK, Lee JY, Kim NY, Park YH, Yoon H, Shin CM, Park YS, Lee DH.

Korean J Gastroenterol. 2015 Jul;66(1):17-26. doi: 10.4166/kjg.2015.66.1.17. Korean.

10.
11.

Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia.

Kusunoki H, Haruma K, Hata J, Ishii M, Kamada T, Yamashita N, Honda K, Inoue K, Imamura H, Manabe N, Shiotani A, Tsunoda T.

Intern Med. 2010;49(20):2195-202.

12.

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.

Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN, Archambault A.

Can J Gastroenterol. 1997 Mar;11(2):127-34.

PMID:
9113812
13.

A placebo-controlled trial of itopride in functional dyspepsia.

Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C.

N Engl J Med. 2006 Feb 23;354(8):832-40. Erratum in: N Engl J Med. 2006 Jul 27;355(4):429.

14.

Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression.

Du HG, Ming L, Chen SJ, Li CD.

World J Gastroenterol. 2014 Nov 28;20(44):16739-44. doi: 10.3748/wjg.v20.i44.16739.

15.

Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.

Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L.

Clin Gastroenterol Hepatol. 2012 Nov;10(11):1239-45. doi: 10.1016/j.cgh.2012.06.036.

PMID:
22813445
16.

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.

Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadström T.

Phytomedicine. 2008 Jun;15(6-7):391-9. doi: 10.1016/j.phymed.2008.04.004.

PMID:
18467083
17.

A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): randomized double-blinded controlled trial.

Kim JB, Shin JW, Kang JY, Son CG, Kang W, Lee HW, Lee DS, Park YC, Cho JH.

J Ethnopharmacol. 2014;151(1):279-86. doi: 10.1016/j.jep.2013.10.033.

PMID:
24239600
19.

The therapeutic effect of Xiaopi-I on functional dyspepsia.

Li H, Yang ZY, Li Y.

Chin J Integr Med. 2013 Mar;19(3):223-7. doi: 10.1007/s11655-011-0951-4.

PMID:
22370870
20.

Efficacy of Gastrosis No.1 compound on functional dyspepsia of spleen and stomach deficiency-cold syndrome: a multi-center, double-blind, placebo-controlled clinical trial.

Zhang SS, Zhao LQ, Wang HB, Wu B, Wang CJ, Huang SP, Shen H, Wei W, Lai YL.

Chin J Integr Med. 2013 Jul;19(7):498-504. doi: 10.1007/s11655-013-1503-x.

PMID:
23818201
Items per page

Supplemental Content

Support Center